Our client is looking to engage experts with insights on CDx (Companion Diagnostics) development trends in Biopharma.
Through this engagement, they would like to speak with experts that have experience with CDx development & launch, alliance management, partner selection and regulatory approvals.
They are scheduling paid 60-minute consultations. They are looking to finish this project before June 30th 2022.
They are hoping to learn more about the following topics:
- Typical CDx deal sizes and structure
- Trends across drugs & indications ( i.e., most likely CDx avenues)
- Current regulatory environment and future evolution - its impact on CDx & market access